392 related articles for article (PubMed ID: 32273342)
1. Depletion of hepatic forkhead box O1 does not affect cholelithiasis in male and female mice.
Feng X; Zhu C; Lee S; Gao J; Zhu P; Yamauchi J; Pan C; Singh S; Qu S; Miller R; Monga SP; Peng Y; Dong HH
J Biol Chem; 2020 May; 295(20):7003-7017. PubMed ID: 32273342
[TBL] [Abstract][Full Text] [Related]
2. Hepatic insulin resistance directly promotes formation of cholesterol gallstones.
Biddinger SB; Haas JT; Yu BB; Bezy O; Jing E; Zhang W; Unterman TG; Carey MC; Kahn CR
Nat Med; 2008 Jul; 14(7):778-82. PubMed ID: 18587407
[TBL] [Abstract][Full Text] [Related]
3. Triglycerides and gallstone formation.
Smelt AH
Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
[TBL] [Abstract][Full Text] [Related]
4. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids.
Kube I; Tardio LB; Hofmann U; Ghallab A; Hengstler JG; Führer D; Zwanziger D
Thyroid; 2021 Jun; 31(6):973-984. PubMed ID: 33231505
[No Abstract] [Full Text] [Related]
5. Inactivation of hepatic microsomal triglyceride transfer protein protects mice from diet-induced gallstones.
Amigo L; Castro J; Miquel JF; Zanlungo S; Young S; Nervi F
Gastroenterology; 2006 Dec; 131(6):1870-8. PubMed ID: 17064699
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients.
Jiang ZY; Parini P; Eggertsen G; Davis MA; Hu H; Suo GJ; Zhang SD; Rudel LL; Han TQ; Einarsson C
J Lipid Res; 2008 Feb; 49(2):464-72. PubMed ID: 18007013
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity.
Zhang Z; Du Z; Liu Q; Wu T; Tang Q; Zhang J; Huang C; Huang Y; Li R; Li Y; Zhao Y; Zhang G; Zhou J; Huang H; Fang Z; He J
Metabolism; 2021 May; 118():154728. PubMed ID: 33581130
[TBL] [Abstract][Full Text] [Related]
8. Forkhead box protein O1 (FoxO1) regulates hepatic serine protease inhibitor B1 (serpinB1) expression in a non-cell-autonomous fashion.
El Ouaamari A; O-Sullivan I; Shirakawa J; Basile G; Zhang W; Roger S; Thomou T; Xu S; Qiang G; Liew CW; Kulkarni RN; Unterman TG
J Biol Chem; 2019 Jan; 294(3):1059-1069. PubMed ID: 30459233
[TBL] [Abstract][Full Text] [Related]
9. Forkhead box transcription factor O1 inhibits cholesterol 7alpha-hydroxylase in human hepatocytes and in high fat diet-fed mice.
Li T; Ma H; Park YJ; Lee YK; Strom S; Moore DD; Chiang JY
Biochim Biophys Acta; 2009 Oct; 1791(10):991-6. PubMed ID: 19463968
[TBL] [Abstract][Full Text] [Related]
10. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H
Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462
[TBL] [Abstract][Full Text] [Related]
11. The G protein-coupled receptor G2A: involvement in hepatic lipid metabolism and gallstone formation in mice.
Johnson LE; Elias MS; Bolick DT; Skaflen MD; Green RM; Hedrick CC
Hepatology; 2008 Oct; 48(4):1138-48. PubMed ID: 18821587
[TBL] [Abstract][Full Text] [Related]
12. Insulin-dependent suppression of cholesterol 7α-hydroxylase is a possible link between glucose and cholesterol metabolisms.
Park WH; Pak YK
Exp Mol Med; 2011 Oct; 43(10):571-9. PubMed ID: 21817852
[TBL] [Abstract][Full Text] [Related]
13. Deletion of liver-specific STAT5 gene alters the expression of bile acid metabolism genes and reduces liver damage in lithogenic diet-fed mice.
Baik M; Kim J; Piao MY; Kang HJ; Park SJ; Na SW; Ahn SH; Lee JH
J Nutr Biochem; 2017 Jan; 39():59-67. PubMed ID: 27816761
[TBL] [Abstract][Full Text] [Related]
14. PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts.
He J; Nishida S; Xu M; Makishima M; Xie W
Gastroenterology; 2011 Jun; 140(7):2095-106. PubMed ID: 21354151
[TBL] [Abstract][Full Text] [Related]
15. Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model.
Liu M; Liu C; Chen H; Huang X; Zeng X; Zhou J; Mi S
Eur J Pharmacol; 2017 Nov; 815():1-9. PubMed ID: 28993159
[TBL] [Abstract][Full Text] [Related]
16. Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1α/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice.
Purushotham A; Xu Q; Lu J; Foley JF; Yan X; Kim DH; Kemper JK; Li X
Mol Cell Biol; 2012 Apr; 32(7):1226-36. PubMed ID: 22290433
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the murine protein kinase Cbeta gene promotes gallstone formation and alters biliary lipid and hepatic cholesterol metabolism.
Huang W; Bansode RR; Xie Y; Rowland L; Mehta M; Davidson NO; Mehta KD
J Biol Chem; 2011 Jul; 286(26):22795-805. PubMed ID: 21550971
[TBL] [Abstract][Full Text] [Related]
18. Proteasome inhibition protects against diet-induced gallstone formation through modulation of cholesterol and bile acid homeostasis.
Lee EJ; Kim MH; Kim YR; Park JW; Park WJ
Int J Mol Med; 2018 Mar; 41(3):1715-1723. PubMed ID: 29286073
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity.
Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
Int J Mol Med; 2016 Mar; 37(3):743-54. PubMed ID: 26847930
[TBL] [Abstract][Full Text] [Related]
20. Aberrant Forkhead box O1 function is associated with impaired hepatic metabolism.
Qu S; Altomonte J; Perdomo G; He J; Fan Y; Kamagate A; Meseck M; Dong HH
Endocrinology; 2006 Dec; 147(12):5641-52. PubMed ID: 16997836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
